Articles

Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats

Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria;Department of Ophthalmology and Optometry, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria
Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria
Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA
Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Department of Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Vol. 99 No. 9 (2014): September, 2014 https://doi.org/10.3324/haematol.2013.099481